Quinazoline derivatives for the treatment of cancer
US7678803B2 · kind B2 · utility
91Cited by
0References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2007 |
| Grant date | Mar 16, 2010 |
| Priority date | — |
| Expiry date | Nov 7, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The current invention is directed toward compounds and pharmaceutically acceptable salts of Formula Iwherein Q1 is CR1, Q2 is N, Q4 and Q5 are each CR1, Q3 is CR2, X1 is N or CRc, Y is CRc, X2 and X3 are each C(R5)(R6), R7 is O. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer The current invention is also directed toward pharmaceutical compositions comprising compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.